COSCIENS Biopharma Inc. sees a mixed week with a slight dip amidst significant recent gains.
In the latest trading session, COSCIENS Biopharma Inc. (CSCI.TO) closed at C$7.55, with no change in its stock price for the day. Over the past week, the stock has decreased by 1.23%, following a remarkable 146.91% increase over the last month and an impressive 175.86% year-to-date performance. Despite these gains, the stock faces some technical challenges as it enters a consolidation period after its recent rally.
Investor takeaway: Investors should consider COSCIENS Biopharma's recent volatility and technical indicators while evaluating their positions. The absence of significant news this week may lead to cautious trading as the stock stabilizes after its prior surges.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
COSCIENS Biopharma Inc.
CSCI.TO
CSCI.TO
COSCIENS Biopharma Inc.
WealthAwesomeMarket cap
$8.49M
52W high
$14.80
52W low
$1.10
1W change
-11.18%
Beta
1.90
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
574.7%
Annualized
90-Day Vol
360.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$9.03
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.01 | C$1.10 – C$58.21 |
| 60 trading days | C$8.50 | C$0.51 – C$140.45 |
| 90 trading days | C$9.03 | C$0.29 – C$279.96 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
COSCIENS Biopharma Inc. is trading 65.3% below its 50-day moving average.
With a market cap of C$8.49 million and a profit margin of 50.7%, COSCIENS Biopharma's financial health seems strong at first glance. However, the negative return on equity (ROE) of -61.8% raises concerns about its operational efficiency.
Bull case
The strong performance over the last month and year suggests that investor sentiment remains positive, especially considering the company's recent financial results, which indicate substantial revenue growth.
Bear case
The significant gap between current trading prices and moving averages suggests potential overvaluation, which could lead to corrections if investor sentiment shifts.
Recent Price Action
COSCIENS Biopharma Inc. (CSCI.TO) has had a flat trading day, closing at C$7.55. Over the past week, the stock dipped by 1.23%, indicating a period of consolidation after a significant rise in previous weeks. The stock has surged 146.91% in the last month and 175.86% year-to-date, reflecting a strong rebound in investor interest and potential recovery in the company's operational activities.
Company News and Developments
This week saw no major news releases or updates from COSCIENS Biopharma. However, recent headlines have included announcements regarding share capital amendments and financial results. Notably, the company announced a share capital amendment involving a 1-for-150 consolidation followed by a 50-for-1 split, effective July 3, 2026. Additionally, COSCIENS reported a net income of C$10.8 million for Q1 2026, primarily driven by income from discontinued operations.
Technical Picture
The technical indicators for COSCIENS Biopharma show that the stock is currently trading significantly below its moving averages, with the 50-day moving average at C$21.73 and the 200-day moving average at C$24.40, representing declines of 65.3% and 69.1%, respectively. The stock's 52-week range has been C$1.10 to C$14.80, indicating that it is currently trading at approximately 47% of its 52-week high. Additionally, the stock has a beta of 1.90, suggesting higher volatility compared to the market.
Advertisement
